Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-06-30
DOI
10.3389/fphar.2021.693048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapy for Nonalcoholic Fatty Liver Disease: Current Options and Future Directions
- (2021) Patrick Campbell et al. CLINICAL THERAPEUTICS
- Chlorogenic Acid Alleviates Colon Mucosal Damage Induced by a High-Fat Diet via Gut Microflora Adjustment to Increase Short-Chain Fatty Acid Accumulation in Rats
- (2021) M. Gui Xie et al. Oxidative Medicine and Cellular Longevity
- Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice
- (2021) Hong-Na Mu et al. FOOD RESEARCH INTERNATIONAL
- The mutual interplay of gut microbiota, diet and human disease
- (2020) Placido Illiano et al. FEBS Journal
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Chlorogenic acid ameliorates obesity by preventing energy balance shift in high‐fat diet induced obese mice
- (2020) Xiaoyun He et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- Chlorogenic Acid Protects Against Indomethacin-Induced Inflammation and Mucosa Damage by Decreasing Bacteroides-Derived LPS
- (2020) Yongwang Yan et al. Frontiers in Immunology
- Chlorogenic acid alleviates acetaminophen-induced liver injury in mice via regulating Nrf2-mediated HSP60-initiated liver inflammation
- (2020) Feifei Hu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Microbial Metabolites: Critical Regulators in NAFLD
- (2020) Xin Dai et al. Frontiers in Microbiology
- Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high‐fat diet fed mice
- (2020) Fahimeh Zamani‐Garmsiri et al. IUBMB LIFE
- Gut microbiota is a factor of risk for obesity and type 2 diabetes
- (2020) T. Y. Demidova et al. TERAPEVTICHESKII ARKHIV
- Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors
- (2019) Iman Alqarni et al. BIOCHEMICAL PHARMACOLOGY
- Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
- (2019) Ting Li et al. Lipids in Health and Disease
- The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon
- (2018) Charlotte Bayer Christiansen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Chlorogenic acid ameliorates alcohol-induced liver injuries through scavenging reactive oxygen species
- (2018) Hyunjin Kim et al. BIOCHIMIE
- Activation of Nrf2 pathway and inhibition of NLRP3 inflammasome activation contribute to the protective effect of chlorogenic acid on acute liver injury
- (2018) Ameng Shi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Coffee consumption and risk of nonalcoholic fatty liver disease
- (2017) Karn Wijarnpreecha et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress
- (2016) Haitao Shi et al. CLINICAL NUTRITION
- Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
- (2016) Thomas A. Lutz et al. CURRENT OPINION IN LIPIDOLOGY
- Glucose-Induced Glucagon-Like Peptide 1 Secretion Is Deficient in Patients with Non-Alcoholic Fatty Liver Disease
- (2014) Christine Bernsmeier et al. PLoS One
- Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis
- (2013) Kiran Bambha et al. LIVER INTERNATIONAL
- Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway
- (2012) Haitao Shi et al. TOXICOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now